Article info
PDFEpidemiology
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort
- Correspondence to Dr Padmanabha Shenoy, Centre for Arthritis and Rheumatism Excellence (CARE), Cochin, Kerala, India; drdpshenoy{at}gmail.com
Citation
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort
Publication history
- Received November 26, 2021
- Accepted January 25, 2022
- First published February 8, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage